Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in Non-Diabetic Hemodialysis Patients
NCT02486744Phase 1Terminated
- Sponsor
- Youngstown State University
- Start
- Mar 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of repository corticotropin injection in end stage renal disease (ESRD) (2 arms), sponsored by Youngstown State University. Primary endpoint: Renal Function at 6 months. Started Mar 2015; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02486744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486744.